5 studies found for:    16208372 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...
Condition: Influenza A Virus, H5N1 Subtype
Interventions: Biological: VRC-AVIDNA036-00-VP;   Biological: Monovalent Influenza Subunit Virion (Inactive H5N1) Vaccine
2 Completed Vaccine for Prevention of Bird Flu
Condition: Influenza, Human
Interventions: Drug: Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005;   Drug: VRC-AViDNA036-00-VP
3 Completed Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
Conditions: Influenza A Virus, H5N1 Subtype;   Influenza A Virus;   Influenzavirus A;   Orthomyxovirdae;   H5N1 Virus
Intervention: Drug: VRC-AVIDNA036-00-VP
4 Completed Safety Study of Avian Flu Vaccine
Conditions: Influenza A Virus, H5N1 Subtype;   Influenza A Virus;   Influenzavirus A;   Orthomyxoviridae;   H5N1 Virus
Intervention: Drug: VRC-AVIDNA036-00-VP
5 Completed Alternative Oseltamivir Dosing Strategies
Condition: Influenza
Intervention: Drug: Oseltamivir

Indicates status has not been verified in more than two years